Does LEDIPASVIR\SOFOSBUVIR Cause Hepatocellular carcinoma? 640 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 640 reports of Hepatocellular carcinoma have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 2.7% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.
640
Reports of Hepatocellular carcinoma with LEDIPASVIR\SOFOSBUVIR
2.7%
of all LEDIPASVIR\SOFOSBUVIR reports
76
Deaths
136
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From LEDIPASVIR\SOFOSBUVIR?
Of the 640 reports, 76 (11.9%) resulted in death, 136 (21.3%) required hospitalization, and 26 (4.1%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 640 reports have been filed with the FAERS database.
What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?
Fatigue (4,609)
Headache (4,203)
Nausea (1,471)
Drug ineffective (1,397)
Hepatitis c (1,076)
Diarrhoea (1,065)
Insomnia (1,021)
Vomiting (623)
Dizziness (604)
Asthenia (558)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
SOFOSBUVIR\VELPATASVIR (161)
Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE
LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT
LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR
LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE
LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB